相似文献
1
Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.
J Am Chem Soc. 2012 Jun 20;134(24):9918-21. doi: 10.1021/ja303904e. Epub 2012 Jun 6.
2
Bispecific HER2 x CD3 antibodies enhance T-cell cytotoxicity in vitro and localize to HER2-overexpressing xenografts in nude mice.
Clin Immunol Immunopathol. 1995 Feb;74(2):185-92. doi: 10.1006/clin.1995.1027.
3
Engineering Bifunctional Antibodies with Constant Region Fusion Architectures.
J Am Chem Soc. 2017 Dec 27;139(51):18607-18615. doi: 10.1021/jacs.7b09641. Epub 2017 Dec 14.
4
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3.
Sci Transl Med. 2018 Oct 17;10(463). doi: 10.1126/scitranslmed.aat5775.
5
Anti-HER-2 anti-CD3 bi-specific antibodies inhibit growth of HCT-116 colorectal carcinoma cells in vitro and in vivo.
Asian Pac J Cancer Prev. 2012;13(6):2795-8. doi: 10.7314/apjcp.2012.13.6.2795.
6
A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells.
J Exp Clin Cancer Res. 2019 Aug 14;38(1):355. doi: 10.1186/s13046-019-1354-1.
7
Engineering high affinity humanized anti-p185HER2/anti-CD3 bispecific F(ab')2 for efficient lysis of p185HER2 overexpressing tumor cells.
Int J Cancer. 1995 Jul 28;62(3):319-24. doi: 10.1002/ijc.2910620315.
8
Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody.
JCI Insight. 2020 Apr 9;5(7):133757. doi: 10.1172/jci.insight.133757.
9
Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers.
ACS Synth Biol. 2021 May 21;10(5):1176-1183. doi: 10.1021/acssynbio.1c00007. Epub 2021 Apr 15.
10
Multiformat T-cell-engaging bispecific antibodies targeting human breast cancers.
Angew Chem Int Ed Engl. 2015 Jun 8;54(24):7022-7. doi: 10.1002/anie.201500799. Epub 2015 Apr 27.
引用本文的文献
1
Cracking the Code: Reprogramming the Genetic Script in Prokaryotes and Eukaryotes to Harness the Power of Noncanonical Amino Acids.
Chem Rev. 2024 Sep 25;124(18):10281-10362. doi: 10.1021/acs.chemrev.3c00878. Epub 2024 Aug 9.
2
Macrophage-engaging peptidic bispecific antibodies (pBsAbs) for immunotherapy a facile bioconjugation strategy.
Chem Sci. 2024 Apr 30;15(29):11272-11278. doi: 10.1039/d4sc00851k. eCollection 2024 Jul 24.
3
Promotion and Detection of Cell-Cell Interactions through a Bioorthogonal Approach.
J Am Chem Soc. 2024 Jun 26;146(25):17334-17347. doi: 10.1021/jacs.4c04317. Epub 2024 May 20.
4
Introduction of Carbonyl Groups into Antibodies.
Molecules. 2023 Dec 1;28(23):7890. doi: 10.3390/molecules28237890.
5
Applications of genetic code expansion technology in eukaryotes.
Protein Cell. 2024 May 7;15(5):331-363. doi: 10.1093/procel/pwad051.
6
Site-specific protein conjugates incorporating Para-Azido-L-Phenylalanine for cellular and in vivo imaging.
Methods. 2023 Nov;219:95-101. doi: 10.1016/j.ymeth.2023.10.001. Epub 2023 Oct 5.
7
Selective and Site-Specific Incorporation of Nonstandard Amino Acids Within Proteins for Therapeutic Applications.
Methods Mol Biol. 2024;2720:35-53. doi: 10.1007/978-1-0716-3469-1_3.
8
Applications of synthetic biology in medical and pharmaceutical fields.
Signal Transduct Target Ther. 2023 May 11;8(1):199. doi: 10.1038/s41392-023-01440-5.
9
The renaissance of chemically generated bispecific antibodies.
Nat Rev Chem. 2021 Feb;5(2):78-92. doi: 10.1038/s41570-020-00241-6. Epub 2021 Jan 19.
10
Aminooxy Click Modification of a Periodate-Oxidized Immunoglobulin G: A General Approach to Antibody-Drug Conjugates with Dye-Mediated Expeditious Stoichiometry Control.
Int J Mol Sci. 2023 Mar 7;24(6):5134. doi: 10.3390/ijms24065134.
本文引用的文献
1
Synthesis of heterobifunctional protein fusions using copper-free click chemistry and the aldehyde tag.
Angew Chem Int Ed Engl. 2012 Apr 23;51(17):4161-5. doi: 10.1002/anie.201108130. Epub 2012 Mar 12.
2
Buy buy bispecific antibodies.
Nat Rev Drug Discov. 2011 Oct 31;10(11):798-800. doi: 10.1038/nrd3581.
3
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies.
Cancer Cell. 2011 Oct 18;20(4):472-86. doi: 10.1016/j.ccr.2011.09.003.
4
Selective formation of covalent protein heterodimers with an unnatural amino acid.
Chem Biol. 2011 Mar 25;18(3):299-303. doi: 10.1016/j.chembiol.2011.01.006.
5
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma.
Blood. 2011 Apr 28;117(17):4542-51. doi: 10.1182/blood-2010-09-306449. Epub 2011 Feb 7.
6
Site-specific coupling and sterically controlled formation of multimeric antibody fab fragments with unnatural amino acids.
J Mol Biol. 2011 Mar 4;406(4):595-603. doi: 10.1016/j.jmb.2011.01.011. Epub 2011 Jan 13.
7
Chemical generation of bispecific antibodies.
Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22611-6. doi: 10.1073/pnas.1016478108. Epub 2010 Dec 13.
8
Readily accessible bicyclononynes for bioorthogonal labeling and three-dimensional imaging of living cells.
Angew Chem Int Ed Engl. 2010 Dec 3;49(49):9422-5. doi: 10.1002/anie.201003761.
9
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.
Int J Cancer. 2010 Nov 1;127(9):2209-21. doi: 10.1002/ijc.25423.
10
Therapeutic antibodies for autoimmunity and inflammation.
Nat Rev Immunol. 2010 May;10(5):301-16. doi: 10.1038/nri2761.
Zotero 插件